Synthroid — Class II drug recall D-1695-2012
Terminated recall by Abbott Laboratories, reported 2012-10-03, distributed nationwide. Defective Container: A number of Synthroid bottles have a localized thin wall defect on the bottom which may p
| Recall number | D-1695-2012 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Abbott Laboratories, Abbott Park, IL, United States |
| Recall initiated | 2012-07-19 |
| Classified | 2012-09-26 |
| Reported by FDA | 2012-10-03 |
| Terminated | 2013-11-01 |
| Distributed | Nationwide (US) |
| Quantity | 42,596 bottles |
| Reason classes | specification failure, packaging |
| NDC | 00074-3727, 00074-3727-13, 00074-3727-19, 00074-3727-71, 00074-3727-72, 00074-3727-90, 00074-4341, 00074-4341-13, 00074-4341-19, 00074-4341-72, 00074-4341-90, 00074-4552, 00074-4552-11, 00074-4552-13, 00074-4552-19, 00074-4552-71, 00074-4552-72, 00074-4552-90, 00074-5182, 00074-5182-11, 00074-5182-13, 00074-5182-19, 00074-5182-71, 00074-5182-72, 00074-5182-90 and 47 more |
| Lot numbers | 18353A8 |
| Expiration dates | 2013-08-31 |
Product
Synthroid (levothyroxine sodium) Tablets USP, 75 mcg, Rx Only, 90-Count Bottle, Abbott Laboratories, North Chicago, IL 60064, NDC: 0074-5182-90.
Reason for recall
Defective Container: A number of Synthroid bottles have a localized thin wall defect on the bottom which may potentially impact the stability of the tablets.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1695-2012. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.